|
|
|
|
Search: 
Latin American Herald Tribune
Venezuela Overview
Venezuelan Embassies & Consulates Around The World
Sites/Blogs about Venezuela
Venezuelan Newspapers
Facts about Venezuela
Venezuela Tourism
Embassies in Caracas

Colombia Overview
Colombian Embassies & Consulates Around the World
Government Links
Embassies in Bogota
Media
Sites/Blogs about Colombia
Educational Institutions

Stocks

Commodities
Crude Oil
US Gasoline Prices
Natural Gas
Gold
Silver
Copper

Euro
UK Pound
Australia Dollar
Canada Dollar
Brazil Real
Mexico Peso
India Rupee

Antigua & Barbuda
Aruba
Barbados
Cayman Islands
Cuba
Curacao
Dominica

Grenada
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines

Belize
Costa Rica
El Salvador
Honduras
Nicaragua
Panama

Bahamas
Bermuda
Mexico

Argentina
Brazil
Chile
Guyana
Paraguay
Peru
Uruguay

What's New at LAHT?
Follow Us On Facebook
Follow Us On Twitter
Most Viewed on the Web
Popular on Twitter
Receive Our Daily Headlines


  HOME | Business & Economy (Click here for more)

Bayer Considers Further Divestments; Q4 Profit Fell

LEVERKUSEN, Germany – Bayer AG said Wednesday that it was considering further divestments in an effort to ease the approval process for its pending takeover of Monsanto Co., as the German chemical producer reported sharply lower fourth-quarter earnings, according to a report from Dow Jones.

Chief Executive Werner Baumann said he expects the Monsanto acquisition to go through in the second quarter as it has received approval from more than half of the necessary competition authorities. However, he indicated that further divestments – beyond last year’s sale of some crop-science businesses to BASF SE – may be necessary to clear final regulatory hurdles.

“We have now also committed to divest our entire vegetable seed business. Certain additional business activities of Bayer and Monsanto may also be sold or out-licensed,” he said.

Baumann said the US foreign investment authority CFIUS has already given its approval and a decision from the European Commission is expected on April 5, Dow Jones added in the report.

Bayer’s Chief Financial Officer Johannes Dietsch said the company is in good financial shape for upcoming financing activities, after it reduced its net financial debt by nearly 70 percent on year to 3.6 billion euros ($4.3 billion), thanks largely to the sale of its share in Covestro AG.

Net profit for the quarter fell 67 percent to 148 million euros, compared with 453 million euro a year earlier, while sales fell 2.6 percent on year to 8.6 billion euros, the company said.

A consensus forecast provided by FactSet had predicted net profit of 745 million euros and sales of 8.63 billion euros.

Bayer attributed the lower earnings to a 455 million-euro tax hit from the US fiscal reforms and ongoing difficulties with its Brazilian crop-science business.

Bayer said that its closely-watched underlying earnings before interest, taxes, depreciation and amortization fell slightly to 1.78 billion euros, from 1.81 billion euros in the year-earlier period, according to the Dow Jones report.

All of Bayer’s four business units reported lower sales in the fourth quarter and all except pharmaceuticals posted lower operating profit, the company said.

The company said its net profit for the full year rose nearly 62 percent to 7.34 billion euros.

For 2018, the company expects sales and earnings at the prior-year level, despite likely currency losses. The forecast includes expected supply interruptions due to plant maintenance, which will cause a 300 million-euro hit to adjusted Ebitda, Bayer said.

Adjusted for currency and scope effects, Bayer said it expects sales to increase by a low-to mid-single-digit percentage, the Dow Jones report added.

 

Enter your email address to subscribe to free headlines (and great cartoons so every email has a happy ending!) from the Latin American Herald Tribune:

 

Copyright Latin American Herald Tribune - 2005-2018 © All rights reserved